Hence, we aimed to conduct a meta-analysis with all accessible case-control studies and trial sequential analysis (TSA) to gain the more precise evidence for the relationship between NAT2 genetic polymorphism and PCa risk. This evidence concerns the gene NAT2 and posterior cortical atrophy.